Interventional Pulmonology is an emerging field in Pulmonary that has dramatically changed the approach to evaluating pulmonary nodules, diagnosis and staging of lung cancer, treatment of lung cancer and diagnosis and treatment of pleural diseases. The Interventional Pulmonology Program at Emory University is the largest and most comprehensive program of its kind in the state of Georgia and in the Southeastern United States.
The program was established to provide patients with access to the latest, minimally invasive, state-of-the art diagnostic and therapeutic modalities to treating lung and pleural diseases. As one of the first programs in the country, the Emory Interventional Pulmonology program has experienced significant growth since its inception. It has three fellowship-trained interventional pulmonologist on staff with access to provide a full range of interventional services at two of the largest hospitals Emory University Hospital and Emory University Hospital Midtown in Atlanta. We have a large catchment area in the Southeastern United states and also provide a consultation service to our Veterans from the Atlanta Veterans Affairs Medical Center.
Research and Recognition
In addition to exceptional clinical care and education, the members of the Interventional Pulmonology program are dedicated to the growth of the field. Research is a significant part of the advancement of the field. Research studies examining the clinical indications and patient outcomes of interventional procedures are important especially as new medical device are introduced to the market. The program consistently presents original research at national and international meetings for the American College of Chest Physicians and the American Thoracic Society.
The IP fellow would be expected to be knowledgeable in all on-going IP-related research studies and to contribute where necessary. Through this experience, the fellow will gain valuable experience in designing and performing literature review prior to IRB submission, conducting clinical research and analyzing research data. The fellow is also expected to produce and present at least one IP-related research study at a national conference or for publication.
We offer an annual two-day intensive course for physicians and affiliates interested in gaining additional experience in Interventional Pulmonology. National and international experts in the field provide lectures and hands-on experience with the latest tools and technology. The course is held each April. For more information, please contact Cicely Ross: email@example.com or Keir Gray: firstname.lastname@example.org.
For questions about enrolling you patients in on-going clinical research studies, please contact the Emory University Transfer service at 1-404-686-8334 and request to speak with Dr. David Berkowitz or Dr. Christine Argento.
The Emory Interventional Pulmonology program offers the least invasive and most up-to-date technology as treatment options. Patients are often evaluated and managed in a multidisciplinary approach with the involvement of our colleagues in Cardio-thoracic Surgery, Medical Oncology, Radiation Oncology, and ENT. This way, a treatment plan is tailored for each individual patient. As a complete Interventional Pulmonary program, we perform the following advanced non-invasive diagnostic, therapeutic and palliative procedures in both the inpatient and outpatient setting.
David Berkowitz, MD
Pulmonary at Emory University Hospital Midtown
Assistant Professor of Medicine
Program Director, Emory Interventional Pulmonary Fellowship
Director, Interventional Pulmonary at Emory Healthcare
Dr. Berkowitz completed his medical residency at Harvard University in Cambridge, MA and did his pulmonary-critical care fellowship training at Emory University in Atlanta, GA. He completed an additional one year of Interventional Pulmonary fellowship training at Harvard University in Boston, MA before returning to Emory to join the Interventional Pulmonary program.
Christine Argento, MD
Assistant Professor of Medicine
More information on the Interventional Pulmonary Fellowship program.